The American Cleaning Institute (ACI)

Research Studies

Year Title Chemical Class Subject
2016

Quantifying the benefits of using read-across and in silico techniques to fulfill hazard data requirements for chemical categories

Author : Kathleen Stanton, Francis H. Kruszewski

Alternative methods
2016

iSTREEM 174; An approach for broad-scale in-stream exposure assessment of down-the-drain chemicals

Author : Katherine E Kapo, Paul C DeLeo, Raghu Vamshi, Christopher M Holmes, Darci Ferrer, Scott D Dyer, Xinhao Wang, Charlotte White-Hull

Risk Assessment
1989

Proceedings of the Joint Government-Industry Workshop on Progress Towards Non-Animal Alternatives to the Draize Test

Author : K. A. Booman, S. J. DeSalva, K. C. Gupta

Animal Alternatives Alternative methods
2009

Use of Read-Across of Existing Hazard Data to Fulfill HPV Chemical Program Requirements without the Need for New Animal Testing

Author : Kruszewski, F., P. DeLeo, K. Stanton, R. Sedlak

Animal Alternatives
2008

Triclocarban: Interim Screening-Level Hazard Characterization

Author : U.S. EPA

Antimicrobials Risk Assessment
2002

Triclocarban: Draft test plan for Triclocarban under the U.S. HPV Chemical Challenge program

Author : SDA

Antimicrobials Risk Assessment
2002

Triclocarban: Draft robust study summaries for Triclocarban under the U.S. HPV Chemical Challenge program

Author : SDA

Antimicrobials Risk Assessment
2014

Quantitative Microbial Risk Assessment of Antibacterial Hand Hygiene Products on Risk of Shigellosis

Author : Schaffner, Donald W.; Bowman, James P.; English, Donald J.; Fischler, George E.; Fuls, Janice L.; Krowka, John F.; Kruszewski, Francis H.

Antimicrobials Efficacy
2019

A Time-Kill Kinetic Study of Four Antiseptic Active Ingredients Versus Strains of Twenty-six Species of Medically Relevant Bacteria and Yeast

Author : J.A. Mitchell, T. Eastman, J. Albright, J.L. Fuls, J. R. Rubino and F. H. Kruszewski

Antimicrobials Safety
2014

FDA Consumer Antiseptics Rule: FDA Request for Data on Safety and Efficacy of Chloroxylenol

Author : Exponent

Antimicrobials Risk Assessment